Issues in co-morbid severe mental illnesses in HIV infected individuals

References

• American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (ADA, APA, AACE, NAASO). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596–601
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Treatment delays in bipolar disorders. American Journal of Psychiatry 1999; 156: 811–812
   PubMed Web of Science ®Google Scholar
• Brandt J, Folstein SE, Folstein MF. Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Annals of Neurology 1988; 23(6)555–561
   PubMedGoogle Scholar
• Burman W, Orr L. Carbemazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz. AIDS 2000; 14: 2793–2794
   PubMed Web of Science ®Google Scholar
• Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clinical Psychology Review 1997; 17: 259–269
   PubMed Web of Science ®Google Scholar
• DAD Study Group, Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, et al. Class of antiretroviral drugs and the risk of myocardial infarction. New England Journal of Medicine 2007; 356: 1723–1735
   PubMed Web of Science ®Google Scholar
• Dato Y, Fujii T, Mizoguchi N, Takata N, Ueda K, Feldman M, et al. Potential interaction between ritonavir and carbemazepine. Phamacotherapy 2000; 20: 851–854
   PubMedGoogle Scholar
• Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of the American Medical Association 2003; 290(11)1467–1473
   PubMed Web of Science ®Google Scholar
• Grace JB, Holmes J. The management of behavioural and psychiatric symptoms in delirium. Expert Opinion on Pharmacotherapy 2006; 7(5)555–561
   PubMed Web of Science ®Google Scholar
• Hugen PW, Burger DM, Brinkman K, ter Hofstede HJ, Schuurman R, Koopmans PP, et al. Carbemazepine-indinavir interaction causes antiretroviral therapy failure. Annals of Pharmacotherapy 2000; 34: 465–470
   PubMed Web of Science ®Google Scholar
• Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. Journal of the American Medical Assciation 1996; 275: 852–857
   PubMed Web of Science ®Google Scholar
• Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The confusion assessment method. A new model for detection of delirium. Annals of Internal Medicine 1990; 113: 941–948
   PubMed Web of Science ®Google Scholar
• Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984–1992. Journal of the American Medical Association 1996; 276: 126–131
   PubMed Web of Science ®Google Scholar
• Letendre S, Capparelli E, Best B, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Simpson D, Ellis R, the CHARTER Group. Better antiretroviral penetration into the central nervous system is associated with lower CSF viral load. Abstract 74, 13th CROI, Denver 2006
   Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck A, Perkins DO, et al. Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353(12)1209–1223
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Schwartz J, Fishman M, Treisman G. AIDS mania. Journal of Neuropsychiatry and Clinical Neuroscience 1997; 9: 277–279
   PubMed Web of Science ®Google Scholar
• Maggi JD, Halman MH. The effect of divalproex sodium on viral load: A retrospective review of HIV-positive patients with manic syndromes. Canadian Journal of Psychiatry 2001; 46: 359–362
   PubMedGoogle Scholar
• McDermott BE, Sautter FJ, Winstead DK, Quirk T. Diagnosis, health beliefs and risk of HIV infection in psychiatric patients. Hospital and Community Psychiatry 1994; 45: 580–585
   PubMedGoogle Scholar
• McKinnon K, Cournos F, Sugden R, Guido JR, Herman R. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. Journal of Clinical Psychiatry 1996; 57: 506–513
   PubMed Web of Science ®Google Scholar
• Meagher DJ, Moran M, Raju B, Gibbons D, Donnelly S, Saunders J, et al. Phenomenology of delirium: Assessment of 100 adult cases using standardised measures. British Journal of Psychiatry 2007; 190: 135–141
   PubMed Web of Science ®Google Scholar
• Navia BA, Cho ES, Petio CK, Price RW. The AIDS dementia complex: II. Neuropathology. Annals of Neurology 1986; 19: 525–535
   PubMed Web of Science ®Google Scholar
• Percudani M, Barbui C, Fortino I, Tansella M, Petrovich L. Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly. Journal of Clinical Psychopharmacology 2005; 25: 468–470
   PubMed Web of Science ®Google Scholar
• Pieper AA, Treisman GJ. Drug treatment of depression in HIV-positive patients: Safety considerations. Drug Safety 2005; 28: 753–762
   PubMed Web of Science ®Google Scholar
• Raivio MM, Laurilla JV, Strandberg TE, Tilvis RS, Pitkala KH. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: A two-year prospective study. American Journal of Geriatric Psychiatry 2007; 15: 1–9
   PubMedGoogle Scholar
• Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy 2007; 27(4)588–594
   PubMedGoogle Scholar
• Sacktor NC, Lyles RH, et al. HIV-associated neurological disease incidence changes: Multicenter AIDS Cohort Study 1990–1998. Neurology 2001; 56: 257–260
   PubMed Web of Science ®Google Scholar
• Saraga M, Preisig M, Zullino DF. Reduced valproate plasma levels possible after introduction of efavirenz in a bipolar patient. Bipolar Disorder 2006; 8: 415–417
   PubMedGoogle Scholar
• Sheehan NL, Brouillete MJ, Delisle MS, Allan J. Possible interaction between lopinavir/ritonavir and valproic acid exacerbates bipolar disorder. Annals of Pharmacotherapy 2006; 40: 157–150
   Google Scholar
• Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996; 8: 261–269
   PubMed Web of Science ®Google Scholar
• Sperber K, Shao L. Neurologic consequences of HIV infection in the era of HAART. AIDS Patient Care and STDs 2003; 17: 509–518
   PubMed Web of Science ®Google Scholar
• Trzepacz PT, Teague GB, Lipowski ZJ. Delirium and other organic mental disorders in a general hospital. General Hospital Psychiatry 1985; 7: 101–106
   PubMed Web of Science ®Google Scholar
• Uldall KK, Berghuis JP. Delirium in AIDS patients: Recognition and medication factors. AIDS Patient Care STDS 1997; 11: 435–441
   PubMedGoogle Scholar